Oragenics Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: May 22, 2024 · CIK: 1174940
| Field | Detail |
|---|---|
| Company | Oragenics INC (OGEN) |
| Form Type | 8-K |
| Filed Date | May 22, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, financials
TL;DR
Oragenics filed a routine 8-K with updated financials/exhibits.
AI Summary
On May 22, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure rather than a significant event. No specific financial figures or material business developments were detailed in the provided excerpt.
Why It Matters
This filing indicates Oragenics, Inc. is providing updated financial statements or exhibits to the SEC, which is a standard regulatory requirement for public companies.
Risk Assessment
Risk Level: low — The filing appears to be a standard procedural update with no immediate indication of significant positive or negative developments.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- May 22, 2024 (date) — Date of earliest event reported
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The provided excerpt states the filing concerns 'Financial Statements and Exhibits' but does not specify which ones.
Does this 8-K report any material changes in Oragenics' business operations?
The excerpt does not detail any material changes; it lists 'Other Events' and 'Financial Statements and Exhibits' as item information.
What is the principal executive office address for Oragenics, Inc.?
The principal executive offices are located at 1990 Main Street, Suite 750, Sarasota, FL 34236.
When was Oragenics, Inc. incorporated?
Oragenics, Inc. was incorporated in Florida (FL).
What is the IRS Employer Identification Number for Oragenics, Inc.?
The IRS Employer Identification Number for Oragenics, Inc. is 59-3410522.
Filing Stats: 432 words · 2 min read · ~1 pages · Grade level 10.3 · Accepted 2024-05-22 08:00:17
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-020964.txt ( ) — 233KB
- ogen-20240522.xsd (EX-101.SCH) — 3KB
- ogen-20240522_lab.xml (EX-101.LAB) — 33KB
- ogen-20240522_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this May 22 nd , 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer